{"id":"W2987681697","doi":"10.3390/cancers11111723","title":"Progression-Free but No Overall Survival Benefit for Adult Patients with Bevacizumab Therapy for the Treatment of Newly Diagnosed Glioblastoma: A Systematic Review and Meta-Analysis","year":2019,"lang":"en","type":"review","venue":"Cancers","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; Sunnybrook Hospital; St. Michael's Hospital","funders":"","keywords":"Bevacizumab; Medicine; Temozolomide; Meta-analysis; Internal medicine; Hazard ratio; Oncology; Progression-free survival; Randomized controlled trial; Glioblastoma; Radiation therapy; Chemotherapy; Surgery; Confidence interval; Cancer research","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01031864,0.00205677,0.01590358,0.004452018,0.0005097742,0.002867699,0.001644075,0.00197569,0.003618809],"category_scores_gemma":[0.02496073,0.001246164,0.03832248,0.004845439,0.0006561058,0.001730746,0.00103808,0.002006266,0.0003292076],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002597304,"about_ca_system_score_gemma":0.003144082,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.007348355,"about_ca_topic_score_gemma":0.01933846,"domain_scores_codex":[0.9935938,0.002892728,0.001974351,0.0006754594,0.0006606911,0.0002029981],"domain_scores_gemma":[0.986623,0.009844217,0.002061926,0.0003368869,0.0009360168,0.0001979935],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.002586197,0.00002285367,0.001949289,0.3891317,0.593049,0.0001048461,0.00006601059,0.0004242377,0.0002448758,0.0001385159,0.0007097911,0.01157256],"study_design_scores_gemma":[0.0008020545,0.0001560805,0.001981035,0.02184488,0.9733517,0.00006949015,0.00002393552,0.000124765,0.00007963364,0.0001795354,0.001368744,0.00001806727],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00362178,0.9946756,0.0003530149,0.000194986,0.0001402843,0.0002150436,0.0004773108,0.0000204632,0.0003013616],"genre_scores_gemma":[0.1673246,0.826622,0.001734972,0.001591154,0.0003088943,0.0008670398,0.001098361,0.00003725933,0.0004156795],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.01590358,"threshold_uncertainty_score":0.05457079,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05231020305544352,"score_gpt":0.3398647239761122,"score_spread":0.2875545209206687,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}